AllAccem Announces Human Dental Products Showcase at IADR / AADR / CADR 2017 General Session and Exhibition
SAN CARLOS, Calif .– (COMMERCIAL THREAD) – AllAccem, Inc., a developer and manufacturer of pharmaceuticals and medical devices, today announced that Karin M. Hold, PhD presents the poster titled “Biocompatibility of AllAccem Gingival Sealant, a New Prescription Dental Device” (Poster # 1349), Thursday, March 23 at 3:45 p.m. PDT at 95e General Session & Exhibition of the International Association for Dental Research (IADR) in collaboration with the 46e
Annual meeting of the American Association for Dental Research
(AADR) and 41st Annual meeting of the Canadian Association for Dental Research (CADR) to be held at the Moscone Center in San Francisco, Calif., March 22-25, 2017. Biocompatibility and safety results generated to date by AllAccem Gingival Sealant indicate potential use as a prescription dental device.
About AllAccem Gingival Sealant
AllAccem Gingival Sealant is a professionally applied human dental product that is being developed to aid in the treatment of gingivitis by inhibiting bacterial adhesion to the surface of the teeth. The sealant contains a proprietary polymer (012-38) which provides a surface barrier preventing oral plaque-forming bacteria from adhering to and colonizing tooth surfaces at the gum line and gumline.
About AllAccem, Inc.
AllAccem is a pharmaceutical and medical device company that develops products for veterinary and human healthcare derived from the company’s proprietary chemistry platform. AllAccem, Inc. currently manufactures, markets and sells SANOS professional veterinary care products.Â®, OticArmorÂ® and CutoGuardÂ®. AllAccem, Inc. is a privately held US company founded in 2005. AllAccem is focused on providing innovative approaches to existing challenges in medical device and pharmaceutical development. For more information, visit http://www.allaccem.com.